loadpatents
name:-0.012198925018311
name:-0.022027015686035
name:-0.00047993659973145
Heyman; Richard A. Patent Filings

Heyman; Richard A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Heyman; Richard A..The latest application filed is for "method and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using rxr modulators".

Company Profile
0.17.9
  • Heyman; Richard A. - Encinitas CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
Grant 7,655,699 - Boehm , et al. February 2, 2
2010-02-02
Method and Pharmaceutical Compositions for Treatment of Anti-Estrogen Resistant Breast Cancer Using RXR Modulators
App 20090093546 - Lamph; William W. ;   et al.
2009-04-09
Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators
App 20070238791 - Lamph; William W. ;   et al.
2007-10-11
Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators
Grant 7,259,188 - Lamph , et al. August 21, 2
2007-08-21
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
App 20060211768 - Evans; Ronald M. ;   et al.
2006-09-21
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
Grant 7,056,954 - Evans , et al. June 6, 2
2006-06-06
Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
App 20060106072 - Boehm; Marcus F. ;   et al.
2006-05-18
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
Grant 6,992,108 - Evans , et al. January 31, 2
2006-01-31
Dimer-selective RXR modulators and methods for their use
App 20040019072 - Canan-Koch, Stacie ;   et al.
2004-01-29
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
App 20040006144 - Evans, Ronald M. ;   et al.
2004-01-08
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
Grant 6,610,883 - Boehm , et al. August 26, 2
2003-08-26
Means For The Modulation Of Processes Mediated By Retinoid Receptors And Compounds Useful Therefor
App 20030105166 - EVANS, RONALD M. ;   et al.
2003-06-05
Treating NIDDM with RXR agonists
Grant 6,521,633 - Heyman , et al. February 18, 2
2003-02-18
Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR Modulators
App 20030013766 - Lamph, William W. ;   et al.
2003-01-16
Treating NIDDM with RXR agonists
App 20020193291 - Heyman, Richard A. ;   et al.
2002-12-19
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
Grant 6,320,074 - Boehm , et al. November 20, 2
2001-11-20
Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones
Grant 6,096,787 - Evans , et al. August 1, 2
2000-08-01
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
Grant 6,043,279 - Boehm , et al. March 28, 2
2000-03-28
Treating NIDDM with RXR agonists
Grant 6,028,052 - Heyman , et al. February 22, 2
2000-02-22
Selective modulation of processes mediated by retinoid X receptors, and compounds useful therefor
Grant 5,990,163 - Evans , et al. November 23, 1
1999-11-23
Treating NIDDM with RXR agonists
Grant 5,972,881 - Heyman , et al. October 26, 1
1999-10-26
Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
Grant 5,968,989 - Evans , et al. October 19, 1
1999-10-19
Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
Grant 5,962,731 - Boehm , et al. October 5, 1
1999-10-05
Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
Grant 5,780,676 - Boehm , et al. July 14, 1
1998-07-14
Use of selective ligands for treatment of disease states responsive to steroid or steroid-like retinoids
Grant 5,668,175 - Evans , et al. September 16, 1
1997-09-16
Dominant negative chimeras of the steroid/thyroid superfamily of receptors
Grant 5,602,009 - Evans , et al. February 11, 1
1997-02-11
Company Registrations
SEC0001584759Heyman Richard A.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed